Overview
White Raven helps biotech and pharma teams move injectable products from development to GMP manufacturing with flexible formulation and aseptic gloveless fill and finish capabilities. The company aims to empower small clinical pharmaceutical and biotech companies with customized solutions, addressing resource limitations, with a target delivery time of 4 months per batch.
Key people
In the news
- One week to go! 🙌 MabDesign's Bioproduction Congress is almost here! 🗓️ September 22–23, 2026 📍Groupama Stadium, Lyon Our Business Developer, Robolge Lenora, will be on-site, ready to talk about how we help biotechs release small to medium batches faster. Book a meeting with him here: https://lnkd.in/eva9mnFZ See you in Lyon! #WeRelease your batch in 4 months #WhiteRaven #BioPC2026 ------- Hi! 👋 We are White Raven, your flexible and agile CDMO partner, specializing in GMP formulation and aseptic filling of injectable drugs.
- Lyon, here we come! Only two weeks to go until this year's MabDesign's Bioproduction Congress in France. 🗓️September 22–23, 2026 📍Groupama Stadium, Lyon. Our Business Developer Robolge Lenora, will be on-site and looking forward to meeting you there. As always, our mission is to help biotechs release their small to medium batches on their timeline. #WeRelease your batch in 4 months #WhiteRaven #BioPC2026 ------- Hi! 👋 We are White Raven, your flexible and agile CDMO partner, specializing in GMP formulation and aseptic
- We are only one week away from the Single-Use Event in Leiden, Netherlands. 🗓️ September 15, 2026 📍Corpus congress centre, Leiden Bio Science Park. Our CEO, Dimitri Woronoff is among this year's speakers, talking about current single-use technologies and how they enable our aseptic filling platform. Our CBO, Ethel Vissers, will also be joining and she would be happy to discuss how we can support your pipeline. As always, our mission is to help biotechs release their small to medium batches on their timeline. #WeRelease your
- Holidays are over, and it's time to head back to the lab. Kids are back at school, and the White Raven team is back at their desks, coffee in hand, ready for a packed second half of the year. The mission has not changed: GMP batches, delivered in under 4 months. Our fill & finish platform never went offline, not even for a day. We consistently deliver: ✓ Minimized contamination risk ✓ Consistent, reproducible operations ✓ Designed to meet Annex 1 expectations Back to school also means back to budget season. Get ahead of it! Fill in
- Two weeks until the Single-use event in Leiden. On September 15, the White Raven team heads to the Single-Use Event to talk about sterile manufacturing, single-use technology, and where the industry is headed. Our CEO, Dimitri Woronoff, takes the stage to share how single-use technology enables a more agile approach to sterile manufacturing. Our CBO, Ethel Vissers, will be there too, exchanging ideas on innovations and development needs with clients and industry colleagues. Fill & finish for small to medium batches? Curious how a
- We are heading to Lyon! In 4 weeks, we will be at the 11th Bioproduction Congress organized by MabDesign, taking place 22–23 September 2026 at Groupama Stadium, Lyon. This event brings together the European biopharmaceutical production community, from big pharma, SMEs, startups, and academic labs, to exchange on the latest innovations shaping the future of bioprocessing, from mAbs and vaccines to cell therapy and novel biologics. Representing White Raven on-site will be our Business Developer, Robolge Lenora. Feel free to reach out
- Bienvenue Grégory ! Ravi de t'accueillir dans l'équipe et l'aventure White Raven. Impatient d'attaquer le prochain sommet avec toi. 🚀🚀🚀
- We will be at Single-Use Event Leiden 2026 on 15 September, and Dimitri Woronoff our CEO is giving one of the keynotes. Dimitri's keynote picks up where the interview below leaves off. Single-use technology unlocked flexibility upstream, but the final step still gets designed around large-volume economics. Clinical-stage and orphan programs need 100 to 20,000 units, not 200,000. That is a structural gap, not an edge case, and it is the reason White Raven was built the way it was: single-use throughout, gloveless robotic isolator,
Something wrong or missing? Send an update. Fixed within 24 hours.